BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9733770)

  • 21. Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4.
    Wu PY; Frit P; Meesala S; Dauvillier S; Modesti M; Andres SN; Huang Y; Sekiguchi J; Calsou P; Salles B; Junop MS
    Mol Cell Biol; 2009 Jun; 29(11):3163-72. PubMed ID: 19332554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DNA binding domain and the C-terminal region of DNA Ligase IV specify its role in V(D)J recombination.
    Malashetty V; Au A; Chavez J; Hanna M; Chu J; Penna J; Cortes P
    PLoS One; 2023; 18(2):e0282236. PubMed ID: 36827388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E1B 55k-independent dissociation of the DNA ligase IV/XRCC4 complex by E4 34k during adenovirus infection.
    Jayaram S; Gilson T; Ehrlich ES; Yu XF; Ketner G; Hanakahi L
    Virology; 2008 Dec; 382(2):163-70. PubMed ID: 18952251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation.
    Simsek D; Jasin M
    Nat Struct Mol Biol; 2010 Apr; 17(4):410-6. PubMed ID: 20208544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonhomologous end joining and V(D)J recombination require an additional factor.
    Dai Y; Kysela B; Hanakahi LA; Manolis K; Riballo E; Stumm M; Harville TO; West SC; Oettinger MA; Jeggo PA
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2462-7. PubMed ID: 12604777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV.
    Koch CA; Agyei R; Galicia S; Metalnikov P; O'Donnell P; Starostine A; Weinfeld M; Durocher D
    EMBO J; 2004 Oct; 23(19):3874-85. PubMed ID: 15385968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. XRCC4/XLF Interaction Is Variably Required for DNA Repair and Is Not Required for Ligase IV Stimulation.
    Roy S; de Melo AJ; Xu Y; Tadi SK; Négrel A; Hendrickson E; Modesti M; Meek K
    Mol Cell Biol; 2015 Sep; 35(17):3017-28. PubMed ID: 26100018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ku recruits the XRCC4-ligase IV complex to DNA ends.
    Nick McElhinny SA; Snowden CM; McCarville J; Ramsden DA
    Mol Cell Biol; 2000 May; 20(9):2996-3003. PubMed ID: 10757784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of the DNA ligase IV-XRCC4 complex with DNA ends and the DNA-dependent protein kinase.
    Chen L; Trujillo K; Sung P; Tomkinson AE
    J Biol Chem; 2000 Aug; 275(34):26196-205. PubMed ID: 10854421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining.
    Audebert M; Salles B; Calsou P
    J Biol Chem; 2004 Dec; 279(53):55117-26. PubMed ID: 15498778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural insights into the role of domain flexibility in human DNA ligase IV.
    Ochi T; Wu Q; Chirgadze DY; Grossmann JG; Bolanos-Garcia VM; Blundell TL
    Structure; 2012 Jul; 20(7):1212-22. PubMed ID: 22658747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of an Xrcc4-DNA ligase IV complex.
    Sibanda BL; Critchlow SE; Begun J; Pei XY; Jackson SP; Blundell TL; Pellegrini L
    Nat Struct Biol; 2001 Dec; 8(12):1015-9. PubMed ID: 11702069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining.
    Ahnesorg P; Smith P; Jackson SP
    Cell; 2006 Jan; 124(2):301-13. PubMed ID: 16439205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA-dependent protein kinase and XRCC4-DNA ligase IV mobilization in the cell in response to DNA double strand breaks.
    Drouet J; Delteil C; Lefrançois J; Concannon P; Salles B; Calsou P
    J Biol Chem; 2005 Feb; 280(8):7060-9. PubMed ID: 15520013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiency.
    Guo C; Nakazawa Y; Woodbine L; Björkman A; Shimada M; Fawcett H; Jia N; Ohyama K; Li TS; Nagayama Y; Mitsutake N; Pan-Hammarström Q; Gennery AR; Lehmann AR; Jeggo PA; Ogi T
    J Allergy Clin Immunol; 2015 Oct; 136(4):1007-17. PubMed ID: 26255102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Processing of DNA for nonhomologous end-joining is controlled by kinase activity and XRCC4/ligase IV.
    Budman J; Kim SA; Chu G
    J Biol Chem; 2007 Apr; 282(16):11950-9. PubMed ID: 17272270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coordinated assembly of Ku and p460 subunits of the DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment.
    Calsou P; Delteil C; Frit P; Drouet J; Salles B
    J Mol Biol; 2003 Feb; 326(1):93-103. PubMed ID: 12547193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XRCC4 controls nuclear import and distribution of Ligase IV and exchanges faster at damaged DNA in complex with Ligase IV.
    Berg E; Christensen MO; Dalla Rosa I; Wannagat E; Jänicke RU; Rösner LM; Dirks WG; Boege F; Mielke C
    DNA Repair (Amst); 2011 Dec; 10(12):1232-42. PubMed ID: 21982441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA ligase IV and XRCC4 form a stable mixed tetramer that functions synergistically with other repair factors in a cell-free end-joining system.
    Lee KJ; Huang J; Takeda Y; Dynan WS
    J Biol Chem; 2000 Nov; 275(44):34787-96. PubMed ID: 10945980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein.
    Jones KR; Gewirtz DA; Yannone SM; Zhou S; Schatz DG; Valerie K; Povirk LF
    Mol Cancer Ther; 2005 Oct; 4(10):1541-7. PubMed ID: 16227403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.